Robert Nelsen, 10% Owner at Neumora Therapeutics, Inc. (NMRA), bought 8,076,400 shares at $17.00 ($25.5M) on 2023-09-19, disclosed to the SEC on 2023-09-20.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $0.00 | 6,576,400 | $0 | 0.0% |
| 2 | $17.00 | 1,500,000 | $25.5M | 100.0% |
| Total | $3.16 avg | 8,076,400 | $25.5M | 100% |
| Filing → |
| SANA | BUY | 2024-02-12 | $8.0M | — | Filing → |
| NMRA | BUY | 2023-09-29 | $2.1M | — | Filing → |
| NMRA | BUY | 2023-09-27 | $1.0M | — | Filing → |